{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T15:44:49Z","timestamp":1787845489516,"version":"build-2784847793"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,4]]},"abstract":"<jats:p>Epithelioid leiomyosarcoma of the uterus is rare and poorly understood. Herein, we characterize a large institutional series of epithelioid leiomyosarcomas aiming to define outcome-determinant diagnostic pathologic features. We also retrieved epithelioid smooth muscle tumors of unknown malignant potential and evaluated a consecutive cohort of leiomyomas for epithelioid subtypes. Of a total of 1177 uterine leiomyosarcomas, 81 (7%) were categorized as epithelioid after review. Epithelioid leiomyosarcoma was strictly defined as having round to polygonal cells with visible pink cytoplasm and round to ovoid nuclei in \u226550% of the tumor volume. Average age was 55 years (range: 26 to 81\u2009y). Median tumor size was 11\u2009cm; tumor was &gt;5\u2009cm in 93% of subjects; 47% were stage 1 at presentation. An infiltrative tumor border was observed, grossly and\/or microscopically, in 89% of cases; necrosis was noted in 80%, and vascular invasion in 47%. Mitotic count in 2.4\u2009mm<jats:sup>2<\/jats:sup> (totalling 10 high-power fields, each field 0.55\u2009mm in diameter) ranged from 3 to 100 (median: 26). All cases had moderate, severe or highly pleomorphic atypia. All cases had 2 or 3 of the following: necrosis, at least moderate atypia and \u22654 mitoses in 2.4\u2009mm<jats:sup>2<\/jats:sup>. Immunohistochemistry revealed frequent expression of smooth muscle markers including SMA (96%), desmin (95%), and caldesmon (81%). HMB45 and Melan-A were negative in 92% and 100% of cases, respectively. Estrogen and progesterone receptors were expressed by 65% and 54% of tumors, respectively. Follow-up information was available in 68 subjects (median: 23\u2009mo, range: 1 to 254); cancer-related death occurred in 63%, and an additional 15% had recurrent or metastatic disease at last follow-up. Disease-specific survival was shorter in epithelioid leiomyosarcoma patients (median: 44 \u2009mo; 35% at 5-y) than in a matched cohort of nonepithelioid leiomyosarcoma (median: 55\u2009mo; 46% at 5-y) (<jats:italic toggle=\"yes\">P<\/jats:italic>=0.03). Three epithelioid smooth muscle tumors of unknown malignant potential were evaluated, all &lt;5\u2009cm in size and with atypia and\/or irregular borders but mitotic count below the threshold for malignancy. Two of these had follow-up available, which was uneventful. Of 142 consecutive leiomyomas assessed, none had epithelioid morphology as defined. Epithelioid leiomyosarcoma is an aggressive neoplasm, sometimes with a remarkably low mitotic count. In the setting of an epithelioid smooth muscle tumor of the uterus, we postulate that the diagnosis of malignancy is made in the presence of \u22652 of the following: moderate or severe atypia, \u22654 mitoses\/2.4\u2009mm<jats:sup>2<\/jats:sup> and tumor cell necrosis. In their absence, the finding of tumor size \u22655\u2009cm, vascular invasion, infiltrative edges or atypical mitoses should be treated with caution, and designation as of at least uncertain malignant potential is warranted.<\/jats:p>","DOI":"10.1097\/pas.0000000000001795","type":"journal-article","created":{"date-parts":[[2021,8,22]],"date-time":"2021-08-22T22:07:39Z","timestamp":1629670059000},"page":"464-475","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":41,"title":["Epithelioid Leiomyosarcoma of the Uterus"],"prefix":"10.1097","volume":"46","author":[{"given":"David B.","family":"Chapel","sequence":"first","affiliation":[{"name":"Division of Women\u2019s and Perinatal Pathology, Department of Pathology, Brigham and Women\u2019s Hospital\u2014Harvard Medical School, Boston, MA"},{"name":"Department of Pathology, University of Michigan\u2014Michigan Medicine, Ann Arbor, MI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marisa R.","family":"Nucci","sequence":"additional","affiliation":[{"name":"Division of Women\u2019s and Perinatal Pathology, Department of Pathology, Brigham and Women\u2019s Hospital\u2014Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley J.","family":"Quade","sequence":"additional","affiliation":[{"name":"Division of Women\u2019s and Perinatal Pathology, Department of Pathology, Brigham and Women\u2019s Hospital\u2014Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Parra-Herran","sequence":"additional","affiliation":[{"name":"Division of Women\u2019s and Perinatal Pathology, Department of Pathology, Brigham and Women\u2019s Hospital\u2014Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,8,20]]},"reference":[{"key":"R1-20250612","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/PAS.0000000000000593","article-title":"Myxoid leiomyosarcoma of the uterus: a clinicopathologic analysis of 30 cases and review of the literature with reappraisal of its distinction from other uterine myxoid mesenchymal neoplasms","volume":"40","author":"Parra-Herran","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"R2-20250612","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/PAP.0000000000000164","article-title":"Myxoid mesenchymal tumors of the uterus: an update on classification, definitions, and differential diagnosis","volume":"24","author":"Busca","year":"2017","journal-title":"Adv Anat Pathol"},{"key":"R3-20250612","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/modpathol.2017.162","article-title":"ZC3H7B-BCOR high-grade endometrial stromal sarcomas: a report of 17 cases of a newly defined entity","volume":"31","author":"Lewis","year":"2018","journal-title":"Mod Pathol"},{"key":"R4-20250612","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/PAS.0000000000000993","article-title":"BCOR internal tandem duplication in high-grade uterine sarcomas","volume":"42","author":"Mari\u00f1o-Enriquez","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"R5-20250612","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/PGP.0000000000000704","article-title":"ALK immunohistochemistry and molecular analysis in uterine inflammatory myofibroblastic tumor: Proceedings of the ISGyP Companion Society Session at the 2020 USCAP Annual Meeting","volume":"40","author":"Parra-Herran","year":"2021","journal-title":"Int J Gynecol Pathol"},{"key":"R6-20250612","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1111\/his.13176","article-title":"Abnormal p53 and p16 staining patterns distinguish uterine leiomyosarcoma from inflammatory myofibroblastic tumour","volume":"70","author":"Schaefer","year":"2017","journal-title":"Histopathology"},{"key":"R7-20250612","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1038\/modpathol.2017.42","article-title":"BCOR is a robust diagnostic immunohistochemical marker of genetically diverse high-grade endometrial stromal sarcoma, including tumors exhibiting variant morphology","volume":"30","author":"Chiang","year":"2017","journal-title":"Mod Pathol"},{"key":"R8-20250612","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1097\/PAS.0000000000001196","article-title":"Novel PLAG1 gene rearrangement distinguishes a subset of uterine myxoid leiomyosarcoma from other uterine myxoid mesenchymal tumors","volume":"43","author":"Arias-Stella","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"R9-20250612","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/00000478-199704000-00003","article-title":"Epithelioid smooth-muscle tumors of the uterus: a clinicopathologic study of 18 patients","volume":"21","author":"Prayson","year":"1997","journal-title":"Am J Surg Pathol"},{"key":"R10-20250612","first-page":"107A","article-title":"Epithelioid smooth muscle tumors of the uterus: a clinicopathologic study of 80 cases","volume":"10","author":"Oliva","year":"1997","journal-title":"Mod Pathol"},{"key":"R11-20250612","first-page":"132A","article-title":"Epithelioid smooth muscle tumors of the uterus","volume":"14","author":"Atkins","year":"2001","journal-title":"Mod Pathol"},{"key":"R13-20250612","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1097\/PAS.0000000000001119","article-title":"Uterine PEComas: a morphologic, immunohistochemical, and molecular analysis of 32 tumors","volume":"42","author":"Bennett","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"R14-20250612","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/PAS.0000000000000133","article-title":"Perivascular epithelioid cell neoplasm (PEComa) of the gynecologic tract: clinicopathologic and immunohistochemical characterization of 16 cases","volume":"38","author":"Schoolmeester","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"R15-20250612","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/PAS.0000000000000349","article-title":"TFE3 translocation-associated perivascular epithelioid cell neoplasm (PEComa) of the gynecologic tract: morphology, immunophenotype, differential diagnosis","volume":"39","author":"Schoolmeester","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"R16-20250612","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1136\/jclinpath-2015-202945","article-title":"Perivascular epithelioid tumours (PEComas) of the gynaecological tract","volume":"68","author":"Conlon","year":"2015","journal-title":"J Clin Pathol"},{"key":"R17-20250612","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/ijgo.12613","article-title":"Uterine sarcomas","volume":"143","author":"Mbatani","year":"2018","journal-title":"Int J Gynecol Obstet"},{"key":"R18-20250612","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1093\/nar\/gku1211","article-title":"BreaKmer: detection of structural variation in targeted massively parallel sequencing data using kmers","volume":"43","author":"Abo","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"R19-20250612","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1158\/2159-8290.CD-11-0184","article-title":"High-throughput detection of actionable genomic alterations in clinical tumor samples by targeted, massively parallel sequencing","volume":"2","author":"Wagle","year":"2012","journal-title":"Cancer Discov"},{"key":"R20-20250612","doi-asserted-by":"crossref","first-page":"201","DOI":"10.7326\/0003-4819-118-3-199302010-00009","article-title":"The risk of determining risk with multivariable models","volume":"118","author":"Concato","year":"1993","journal-title":"Ann Intern Med"},{"key":"R21-20250612","doi-asserted-by":"crossref","first-page":"521","DOI":"10.21147\/j.issn.1000-9604.2017.06.06","article-title":"Outcome and prognostic factors in 110 consecutive patients with primary uterine leiomyosarcoma: A Rare Cancer Network study","volume":"29","author":"Pellanda","year":"2017","journal-title":"Chin J Cancer Res"},{"key":"R22-20250612","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1002\/cncr.23245","article-title":"Prognostic factors and survival in 1396 patients with uterine leiomyosarcomas: emphasis on impact of lymphadenectomy and oophorectomy","volume":"112","author":"Kapp","year":"2008","journal-title":"Cancer"},{"key":"R23-20250612","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1097\/IGC.0000000000000370","article-title":"Clinical outcomes and prognostic markers in uterine leiomyosarcoma: a population-based cohort","volume":"25","author":"Garcia","year":"2015","journal-title":"Int J Gynecol Cancer"},{"key":"R24-20250612","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1365-2559.2009.03231.x","article-title":"Uterine sarcomas in Norway. A histopathological and prognostic survey of a total population from 1970 to 2000 including 419 patients","volume":"54","author":"Abeler","year":"2009","journal-title":"Histopathology"},{"key":"R25-20250612","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1002\/1097-0142(197604)37:4<1853::AID-CNCR2820370433>3.0.CO;2-E","article-title":"Mesenchymal tumors of the uterus. VI. Epithelioid smooth muscle tumors including leiomyoblastoma and clear-cell leiomyoma: a clinical and pathologic analysis of 26 cases","volume":"37","author":"Kurman","year":"1976","journal-title":"Cancer"},{"key":"R26-20250612","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1097\/00000478-199403000-00002","article-title":"Epithelioid leiomyosarcoma of the skin and subcutaneous tissue. Clinicopathologic, immunohistochemical, and ultrastructural study of five cases","volume":"18","author":"Suster","year":"1994","journal-title":"Am J Surg Pathol"},{"key":"R27-20250612","doi-asserted-by":"crossref","first-page":"468","DOI":"10.5858\/2002-126-0468-ELOTED","article-title":"Epithelioid leiomyosarcoma of the external deep soft tissue","volume":"126","author":"Yamamoto","year":"2002","journal-title":"Arch Pathol Lab Med"},{"key":"R28-20250612","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1078\/0344-0338-00139","article-title":"Epithelioid leiomyosarcoma of the uterus with oncocytic change","volume":"197","author":"Nguyen","year":"2001","journal-title":"Pathol Res Pract"},{"key":"R29-20250612","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/00000478-200402000-00013","article-title":"Uterine epithelioid leiomyosarcomas with clear cells: reactivity with HMB-45 and the concept of PEComa","volume":"28","author":"Silva","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"R30-20250612","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/PAS.0000000000001572","article-title":"Genomic profiling aids classification of diagnostically challenging uterine mesenchymal tumors with myomelanocytic differentiation","volume":"45","author":"Selenica","year":"2021","journal-title":"Am J Surg Pathol"},{"key":"R31-20250612","doi-asserted-by":"crossref","first-page":"E2126","DOI":"10.3390\/cancers12082126","article-title":"Genomic database analysis of uterine leiomyosarcoma mutational profile","volume":"12","author":"Astolfi","year":"2020","journal-title":"Cancers"},{"key":"R32-20250612","article-title":"Uterine PEComas: correlation between melanocytic marker expression and TSC alterations\/TFE3 fusions","author":"Bennett","year":"2021","journal-title":"Mod Pathol"},{"key":"R33-20250612","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1097\/PAS.0000000000001239","article-title":"PGR gene fusions identify a molecular subset of uterine epithelioid leiomyosarcoma with rhabdoid features","volume":"43","author":"Chiang","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"R34-20250612","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/PGP.0b013e3181af21ce","article-title":"Epithelioid leiomyosarcoma of the uterus containing sex cord-like elements","volume":"29","author":"Lee","year":"2010","journal-title":"Int J Gynecol Pathol"},{"key":"R35-20250612","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/PAS.0000000000001348","article-title":"Uterine tumor resembling ovarian sex cord tumor (UTROSCT): a morphologic and molecular study of 26 cases confirms recurrent NCOA1-3 rearrangement","volume":"44","author":"Goebel","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"R36-20250612","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1177\/106689690201000314","article-title":"Rhabdoid epithelioid leiomyosarcoma of the uterine corpus: a case report and literature review","volume":"10","author":"Levine","year":"2002","journal-title":"Int J Surg Pathol"},{"key":"R37-20250612","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1111\/j.1447-0756.2010.01454.x","article-title":"A case of tumor lysis syndrome following chemotherapy for a uterine epithelioid leiomyosarcoma with focal rhabdomyosarcomatous differentiation","volume":"37","author":"Hiraizumi","year":"2011","journal-title":"J Obstet Gynaecol Res"},{"key":"R38-20250612","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s00508-007-0822-3","article-title":"Epithelioid leiomyosarcoma with rhabdoid features","volume":"119","author":"Yorulmaz","year":"2007","journal-title":"Wien Klin Wochenschr"},{"key":"R39-20250612","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/his.13515","article-title":"Predictors of adverse outcome in uterine smooth muscle tumours of uncertain malignant potential (STUMP): a clinicopathological analysis of 22 cases with a proposal for the inclusion of additional histological parameters","volume":"73","author":"Gupta","year":"2018","journal-title":"Histopathology"},{"key":"R40-20250612","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1038\/s41379-020-0546-8","article-title":"Molecular and clinicopathologic characterization of intravenous leiomyomatosis","volume":"33","author":"Ordulu","year":"2020","journal-title":"Mod Pathol"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000001795","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T17:00:36Z","timestamp":1749747636000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000001795"}},"subtitle":["Modern Outcome-based Appraisal of Diagnostic Criteria in a Large Institutional Series"],"short-title":[],"issued":{"date-parts":[[2021,8,20]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000001795","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8,20]]}}}